Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

@inproceedings{Zhang2017TransarterialC,
  title={Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis},
  author={Xiuping Zhang and Kang Wang and Meng Wang and Guang Yang and Xiaofei Ye and Meng-chao Wu and Shu-Qun Cheng},
  booktitle={Oncotarget},
  year={2017}
}
BACKGROUND The benefits of transarterial chemoembolization plus sorafenib (TACE-S) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) remain controversial. We compared the effectiveness and safety of TACE-S and TACE for HCC with PVTT. METHODS The Cochrane Library, PubMed, EMBASE, Chinese National Knowledge Infrastructure, VIP, Wan Fang, and Sino Med databases were systematically searched for studies of HCC with PVTT treated using TACE-S. Two authors independently… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Jun Yin, W T Bo, +4 authors Le-qun Li
Journal of clinical and translational hepatology • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Efficacy and safety analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus

LD Luo, Z. Luo
Journal Chinese Physician • 2014
View 8 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…